GlassScriptPhysician profile
Danielle Greenfield
NPI 1639668817
$6,540.76
in general payments reported to CMS, 2019-2025
29 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $649 · 2021: $1,873 · 2022: $1,690 · 2023: $1,050 · 2024: $418 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,059.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $2,884.46 | 2020-2022 | |
| Smith+Nephew, INC. | $803.89 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Stryker Corporation | $618.39 | 2020-2025 | Prostep Mica, Sonicanchor, Augment Injectable |
| Organogenesis INC. | $557.06 | 2023-2025 | Puraply, Puraply Wound Matrix |
| Paragon 28, INC. | $391.20 | 2019-2023 | Portfolio |
| Zimmer Biomet Holdings, INC. | $221.14 | 2020-2021 | |
| Integra Lifesciences Corporation | $177.68 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $108.39 | 2023-2025 | Nuzyra |
| Arteriocyte Medical Systems, INC. | $99.15 | 2021 | |
| Orthofix Medical, INC. | $98.41 | 2022-2024 | Physio-Stim |
| Kerecis Limited | $69.10 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Nevro Corp. | $62.78 | 2024 | Senza |
| Ibsa Pharma INC. | $56.31 | 2023-2025 | Tirosint, Licart, Tirosint |
| Resmed Corp | $48.09 | 2022-2023 | |
| Convatec INC. | $41.40 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $33.03 | 2024 | |
| Arthrex, INC. | $32.45 | 2022 | |
| International Life Sciences | $30.85 | 2024 | Flexband |
| Solventum Corporation | $24.15 | 2025 | Activ.A.C. |
| Acera Surgical, INC. | $23.45 | 2022 | |
| Averitas Pharma INC. | $22.84 | 2023 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.84 | 2023 | Jublia |
| Grt US Holding, INC. | $20.48 | 2022 | |
| Dynasplint Systems INC. | $19.76 | 2025 | Dynasplint |
| Abbvie INC. | $17.22 | 2023 | |
| Urgo Medical North America, LLC | $15.89 | 2025 | Urgok2 |
| Depuy Synthes Sales INC. | $14.32 | 2022 | |
| Paladin Technology Solutions | $13.62 | 2023 | |
| Eclipse Technology Solutions INC. | $13.41 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Greenfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.